Kyowa Kirin
The application that simplifies rickets assessment
Raquitool, the application that helps clinical professionals prevent errors in rickets assessment
ContactKyowa Kirin's contribution to rickets assessment
The diagnosis and treatment of rickets require collaboration among pediatricians, endocrinologists, and pediatric nephrologists, who work together to address the complexities of this disease. Among the companies contributing to this field is Kyowa Kirin, a leading Japanese pharmaceutical company specializing in therapies for rare diseases.
In July 2022, Kyowa Kirin, in collaboration with Navandu—an innovative company in digital products and services for the healthcare sector, now part of SNGULAR—launched the Raquitool project. This application is designed to facilitate the accurate and early assessment of rickets, helping specialists evaluate patients suspected of having this disease, which often presents significant diagnostic challenges
The use of Raquitool highlights its relevance as a diagnostic support tool
Since its launch, Raquitool has proven to be an effective tool in clinical practice, accumulating over 1,800 accesses by specialists in pediatric nephrology and endocrinology. Among its most used features are the analysis of normal range values for biochemical variables and phosphorus renal management calculations, both essential for accurate diagnosis. Additionally, the increase in report generation reflects a high level of interaction and trust in the tool, which supports clinical judgment by documenting detailed results.
Contact us
We help you implement and manage digital solutions that transform and redefine the ways pharmaceutical industry and healthcare professionals interact